Riskpilot← Back to searchSign inGet full accessWheeze Aktiebolag
ABActiveOrg 5590877808Upplandsgatan 64General medical practice activities · NACE 8621Est. 20162 employees
Revenue 2025
SEK 10,2M
+5% vs 2024
EBITDA margin
34.8%
+22% vs 2024
Equity ratio
64.2%
Financial strength
Net profit 2025
SEK 2,6M
+42% vs 2024
| Revenue | SEK 10,2M | +5% |
| EBITDA | SEK 3,6M | +22% |
| Net profit | SEK 2,6M | +42% |
| Total assets | SEK 19,2M | +18% |
| Equity | SEK 12,4M | +21% |
| Employees | 2 | — |
Legal name
Wheeze Aktiebolag
Org number
5590877808
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
29 november 2016
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bedriva läkarpraktik.
Address
Upplandsgatan 64
Email
lindgrentherese@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 8 055 | 9 294 | 10 238 | 9 747 | 10 242 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 838 | 4 153 | 3 722 | 2 929 | 3 561 |
| Depreciation & amort. | −566 | −553 | −0 | −0 | −0 |
| EBIT | 3 272 | 3 600 | 3 722 | 2 929 | 3 561 |
| Net financials | −7 | −8 | 117 | 212 | 127 |
| Profit before tax | 2 554 | 2 700 | 2 863 | 2 353 | 3 338 |
| Tax | −550 | −560 | −604 | −510 | −722 |
| Net profit | 2 004 | 2 140 | 2 259 | 1 843 | 2 616 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 9 065 | 11 431 | 14 186 | 16 301 | 19 237 |
| Equity | 5 111 | 6 895 | 8 778 | 10 220 | 12 356 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 282 | 972 | 868 | 753 | 1 203 |
| Total debt | 1 282 | 972 | 868 | 753 | 1 203 |
EBITDA margin
34.8%
This company
15.8%
Market median
+120% vs market
20212025
Equity ratio
64.2%
This company
38.2%
Market median
+68% vs market
20212025
Return on equity
21.2%
This company
18.4%
Market median
+15% vs market
20212025
Net profit margin
25.5%
This company
8.1%
Market median
+215% vs market
20212025
Asset turnover
0.53×
This company
1.12×
Market median
-53% vs market
20212025
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BC Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wheeze Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Christer Eriksson | Audit | 0 companies |
| Eva Therése Lindgren | Board of Directors | 0 companies |
| Mats Halldin | Deputy Board Member | 0 companies |